Editorial Board

Dr Pan Pantziarka is the Program Director for Drug Repurposing at the Anticancer Fund and the coordinator of the Repurposing Drugs in Oncology (ReDO) project (www.redo-project.org), an international collaboration between the Anticancer Fund and the US not-for-profit GlobalCures. In addition to publishing papers on specific non-cancer drugs with the potential to be repurposed for oncological use, the ReDO project is engaged on cancer policy work related to drug licensing and similar issues. Other research interests include the rare genetic cancer condition Li Fraumeni Syndrome (LFS) and the development of computational models of tumour growth.

Dr Pantziarka is also the co-founder and Chairman of the George Pantziarka TP53 Trust (www.tp53.org.uk), a UK-based patient advocacy and support organisation for sufferers LFS.